The Pigmentary Impact of Acne
Pigmentary sequelae from acne flares can be more distressing to patients than acne itself, according to Brooklyn, N.Y., dermatologist Dr. Hilary Baldwin. Next Steps in Derm, in partnership with Skin of Color Update, interviewed Dr. Baldwin, who shares how her treatment approach has changed over the years. Find out if dermatology clinicians should take an acne-first approach or treat hyperpigmenta …
Pigmentary sequelae from acne flares can be more distressing to patients than acne itself, according to Brooklyn, N.Y., dermatologist Dr. Hilary Baldwin. Next Steps in Derm, in partnership with Skin of Color Update, interviewed Dr. Baldwin, who shares how her treatment approach has changed over the years. Find out if dermatology clinicians should take an acne-first approach or treat hyperpigmenta … 
During a recent lecture at the Skin of Color Update conference, Hye Jin (Leah) Chung, MD, MMSc, FAAD, shared clinical pearls for managing dermatologic conditions in Asian patients. Dr. Chung emphasized that Asian skin possesses unique characteristics, such as a higher ceramide content than both White and Black skin, and a significantly higher propensity for reactivity. This sensitivity directly … 
Atopic dermatitis (AD) that’s not fully under control was the subject of two Everyday Health articles: one on treatment “red flags” and another on insufficient care that’s accepted by patients as “good enough.” With so many factors contributing to AD flares, discerning when a treatment isn’t working or has stopped working can be a challenge for both patients and clinicians. Additiona … 
Next Steps in Derm, in partnership with Skin of Color Update, interviewed Dr. Raj J. Chovatiya, associate professor at Rosalind Franklin University of Medicine and Science Chicago Medical School, about diagnosing and treating atopic dermatitis in patients with darker skin tones. Learn what he tells his trainees about diagnosing atopic dermatitis in skin of color. Find out how a greater understand … 
The past 18 months has seen an unprecedented wave of FDA approvals in dermatology, significantly expanding the therapeutic options for treatment of inflammatory skin diseases. At the 2025 Skin Of Color Update in New York City, conference co-chair Dr. Andrew Alexis highlighted some of these new medications and new indications for others. Importantly, many of these pivotal clinical trials includ …